Executive Vice President, General Counsel and Secretary · Amgen Inc. (AMGN)

Jonathan Graham

A named executive officer of Amgen in every fiscal year CompBrief holds from FY2016 to FY2019. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2019

$7,239,970

Salary $959,113Stock awards $3,959,666

FY2018: $5,345,358

2nd of 5 named executive officers at Amgen by FY2019 total.

5 named officers on file for Amgen, FY2019

Jonathan Graham’s pay file — $29

  • 4 fiscal years of pay, line by line
  • 7 equity grants, each cited to its filing
  • AMGN’s disclosed peer group of 15 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Amgen’s whole pay program stands against its peers

  • Amgen’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on AMGN→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 7, 2020 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Jonathan Graham’s full pay file as a PDF — free

More than this page: up to 10 years of Jonathan’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Jonathan Graham compensation by year

Amgen Summary Compensation Table · all 4 fiscal years held
In US dollars, as Amgen reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018FY2019
Salary$916,789$932,577$938,596$959,113
Bonus$1,000,000$0$0$0
Stock awards$1,609,898$1,749,939$1,959,878$3,959,666
Option awards$689,990$749,997$839,983$839,997
Non-equity incentive$1,165,000$858,000$1,402,000$1,220,000
Pension and deferred compensation$0$0$0$0
All other$1,038,668$231,695$204,901$261,194
Total$6,420,345$4,522,208$5,345,358$7,239,970

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Amgen Inc. DEF 14A filed April 7, 2020, accession 0001193125-20-100447, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Amgen Inc. filed document, accession 0001193125-20-100447. Every figure is read from that document and cited to the page and table it appears in. Filed April 7, 2020.

$6.4M
$4.5M
$5.3M
$7.2M
FY16
FY17
FY18
FY19
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2019 year-end
TypeUnvested unitsValue at year-endExercise price
RSU19,109$4,606,607—
PSU15,593$3,759,005—
PSU15,180$3,659,443—
PSU11,600$2,796,412—
Option18,247—$162.60
Option8,516—$156.35
Option27,568—$177.31
Option24,291—$177.46

Per the Outstanding Equity Awards at Fiscal Year-End table in Amgen Inc.'s FY2019 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

35 Form 4 lines since the FY2019 proxy (filed April 7, 2020)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-05-07Tax withholding—499$331.1139,712
2026-05-06Tax withholding—408$329.5940,211
2026-05-05Grant or award derivative—17,022$329.5917,022
2026-05-05Grant or award—2,609$0.0040,619
2026-05-02Tax withholding—647$329.8238,620
2026-05-02Tax withholding—610$329.8238,010
2026-03-16Tax withholding—5,353$366.2139,267
2026-03-03Grant or award—10,723$0.0044,478

The 8 most recent of 35 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Amgen’s named executive officers, FY2019

as the company reported each
Named executive officerRoleFY2019 total
Robert A. BradwayChief Executive Officer and President$19,612,793
Jonathan Graham · this pageExecutive Vice President, General Counsel and Secretary$7,239,970
David MelineExecutive Vice President and Chief Financial Officer$6,673,570
Murdo GordonExecutive Vice President, Global Commercial Operations$6,655,836
David M. ReeseExecutive Vice President, Research and Development$6,537,925

The full Amgen compensation record

free company brief

This page is one person within Amgen's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Amgen proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Amgen's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Jonathan Graham's compensation dossier · One-time report. No refunds.